Navigation Links
Part I. Not for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.
Date:7/18/2014

is announcement.

Part IINot for release, publication or distribution, in whole or in part, directly or indirectly, in, into or from any jurisdiction where to do so would constitute a violation of the relevant laws or regulations of such jurisdiction.RECOMMENDED COMBINATION OF SHIRE PLC AND ABBVIE INC.1.
IntroductionThe Boards of Shire and AbbVie are pleased to announce that they have reached agreement on the terms of a recommended combination of Shire with AbbVie.

2.
The MergerUnder the terms of the Merger, Shire Shareholders will be entitled to receive:
in respect of each Shire Share: £24.44 in cash and 0.8960 New AbbVie Shares

  • The Merger terms represent:
  • An indicative value of £52.48 per Shire Share based on AbbVie's closing share price of $53.52 on 17 July 2014, the Latest Practicable Date; and
  • An indicative value of £53.19 per Shire Share based on AbbVie's 30-day Volume-Weighted Average Price of $54.83 to 17 July 2014, the Latest Practicable Date.
  • The indicative value of £53.19 per Shire Share values the entire issued and to be issued share capital of Shire on a fully diluted basis at approximately £32 billion and represents:
  • A premium of approximately 53 per cent. to the price of Shire Shares of £34.67 on 2 May 2014, being the last Business Day prior to AbbVie's initial proposal;
  • A premium of approximately 42 per cent. to the price of Shire Shares of £37.38 on 19 June 2014, being the last Business Day prior to the commencement of the offer period; and
  • An implied Enterprise Value / Last Twelve Months EBITDA multiple of approximately 24x.
  • On the basis of approximately 536 million New AbbVie Shares being issued pursuant to the Merger, following the Transaction, Shire Shareholders will hold New AbbVie Shares representing approximately 25 per cent. of the issued share capital of New AbbVie and AbbVie Stockholders will hold New AbbVi
    '/>"/>

  • SOURCE AbbVie Inc.
    Copyright©2014 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

    Related medicine technology :

    1. North American Drug Delivery Technologies Market (Metered Dose Inhalers, Needle-Free Injectors, Auto-Injectors, Nasal Sprays, Transdermal Patches, Nebulizers, Infusion Pumps, Drug Eluting Stents, Sustained Release, Ocular Implants) - Forecasts To 20
    2. aTyr Pharma Announces Publication of a Rare Muscle Disease Associated with Regulation of a Potential Physiocrine
    3. BioLineRx Reports Publication in Peer Review Journal of Positive Phase 1/2 Results in Stem Cell Mobilization for Multiple Myeloma
    4. Micell Technologies Announces DESSOLVE I Manuscript Accepted for Publication in American College of Cardiologys Cardiovascular Interventions Journal
    5. Avanir Pharmaceuticals Announces Publication of AVP-825 Pharmacokinetic Data in Journal "Headache"
    6. Avanir Pharmaceuticals Announces Publication of PRISM Pseudobulbar Affect Registry Findings
    7. BioLineRx Announces Publication of Positive Pre-Clinical Results for BL-8040 in Treatment of Thrombocytopenia
    8. Sangamo BioSciences Announces Publication of First Demonstration of Inactivation of Extra Chromosome Responsible for Down Syndrome
    9. SI-BONE, Inc. Announces Publication of Postmarket Surveillance Safety Data on First 5,319 Patients Treated with iFuse Implant System
    10. Metabolic Solutions Development Company announces publication of data describing potential for new drugs to maintain pancreatic beta-cells in treating diabetes
    11. Sanofi and Regeneron Announce Publication of Positive Phase 2a Results of Dupilumab in Asthma in the New England Journal of Medicine
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:5/29/2015)... May 29, 2015 A six-hour certification program on ... presented at the Cannabis World Congress & Business Exposition ... York, NY .  Taking place on Wednesday, June 17 ... of education at the leading event on the East Coast ... Led by Clover Leaf University, the first cannabis university to ...
    (Date:5/29/2015)... , May 28, 2015 Research ... addition of Jain PharmaBiotech,s new report "Cardiovascular ... to their offering. Drug delivery to ... other systems because of the anatomy and physiology ... nutrients to all organs of the body. Drugs ...
    (Date:5/29/2015)... 29, 2015 Research and ... of the "Surgical/Operating Microscopes Market by Application ... report to their offering.      ... market is poised to reach $806.6 million by ... CAGR of 12.3% from 2015 to 2020. , ...
    Breaking Medicine Technology:Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 2Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 3Cannabis Business Certification and Career Workshops Presented at New York Trade Show & Conference 4Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 2Global Cardiovascular Drug Delivery Market 2015 - Technologies, Markets and Companies 3Surgical/Operating Microscopes Market by Application & End User - Global Forecast to 2020 for the $806 Million Industry 2
    ... , WALTHAM, Mass., ... authority on medical technology market intelligence, the nearly $1.2 billion global ... chose to delay or forego treatment as a result of the ... by 2014, will return to the strong pre-recession growth rates of ...
    ... N.J. and CHICAGO, Nov. 30 Today at the 95th ... Society of North America (RSNA), Bayer HealthCare Pharmaceuticals Inc. announced ... III clinical trial to evaluate the efficacy and safety of ... plaques in the brain, which are a pathological hallmark of ...
    Cached Medicine Technology:Facial Injectables Emerge From the Recession 2Facial Injectables Emerge From the Recession 3Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 2Bayer HealthCare Pharmaceuticals Initiates Phase III Trial with Florbetaben PET Tracer for Imaging of Cerebral beta-Amyloid Plaques, a Pathological Hallmark of Alzheimer's Disease 3
    (Date:5/29/2015)... Red Hot & Blue Restaurants , ... & Blue restaurant at 525 New Waverly Place in Cary, ... “The Red Hot & Blue Restaurant was previously located in ... have moved to a new location in the center,” said ... all the activities on the Promenade–with outdoor seating and service, ...
    (Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... unit have reached a confidential Risperdal lawsuit ( ... allegedly developed gynecomastia due to his use of ... case had been selected for the third bellwether ... a mass tort litigation underway in Pennsylvania’s Philadelphia ...
    (Date:5/29/2015)... New York, New York (PRWEB) May 29, 2015 ... and distributor of patented products, announces that it has ... Chat Room, a technology patent that aims to let ... various industry experts in real time. , "This is ... Expert Chat Room " said Scott J. Cooper, CEO ...
    (Date:5/29/2015)... 2015 The print component of “Skin ... of approximately 250,000 and an estimated readership of 750,000. ... social media strategy, and across a network of top ... version of the campaign, click here. , ... Inside, the actress, model and producer details her skin ...
    (Date:5/29/2015)... May 29, 2015 The campaign focuses ... as a number of specific concerns within, including the ... and mental health in the workplace. We are encouraged ... The campaign also brings special focus to people living ... speak up and seek help from healthcare professionals and ...
    Breaking Medicine News(10 mins):Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2
    ... HealthDay Reporter , TUESDAY, April 3 (HealthDay News) -- Recent ... related deaths may be the result of a glitch in ... than a treatment breakthrough, a new study suggests. ... time, between 2003 and 2009, the number of admissions to ...
    ... breast cancer (IBC) is a very aggressive, often misunderstood type ... compared with other types of breast cancer. The five-year survival ... survival rate for other types of breast cancer. The reason ... and often spreads quickly to other parts of the body, ...
    ... Health and Sexuality Survey, involving nearly 2000 people, describes the ... are kisses, caresses and vaginal penetration. The main causes of ... study published in one of the world,s biggest sexuality journals ... that influence sexual activity amongst elderly people in Spain. ...
    ... By Carina Storrs HealthDay Reporter , TUESDAY, ... top "super foods," and other cruciferous vegetables may improve your ... In a study of women in China diagnosed with breast ... vegetables were 62 percent less likely to die of breast ...
    ... Reporter , TUESDAY, April 3 (HealthDay News) -- People ... risk of an eye condition called retinal detachment, a ... to fight a variety of bacterial infections, have ... optic neuropathy and retinal hemorrhages. But this is the ...
    ... Plants have a lot to teach us about how our planet ... , in which plants play an important role, can inspire us to ... movies can teach us about our planet,s vegetation? The public has ... , a professor of plant physiology at the University of California, Riverside ...
    Cached Medicine News:Health News:Reported Decline in U.S. Pneumonia Deaths May Be False: Study 2Health News:Reported Decline in U.S. Pneumonia Deaths May Be False: Study 3Health News:Researchers develop a new cell and animal model of inflammatory breast cancer 2Health News:Researchers develop a new cell and animal model of inflammatory breast cancer 3Health News:62 percent of men and 37 percent of women over the age of 65 are sexually active 2Health News:Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study 2Health News:Veggies Like Broccoli, Cabbage May Help Fight Breast Cancer: Study 3Health News:Antibiotics Linked to Retinal Detachment Risk 2Health News:Antibiotics Linked to Retinal Detachment Risk 3Health News:What can Hollywood teach us about our planet? 2Health News:What can Hollywood teach us about our planet? 3
    ... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    ... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
    Medicine Products: